Hey pat. I am no expert when it comes to medical stocks, but...

Hey pat.

I am no expert when it comes to medical stocks, but just via gleening what I can from the hc forum, time is a factor.

We have runs on the board, lots of good results, and even better result with combo therapy with yervoy and keytruda. These results were metioned during our last podium presentation earlier this year.

The problem we have is that, the number of participants in the studies underway (in which we have great results) is small and limited. The combos need to be proven up with greater numbers.

There are 2 issues with that,

1. The only people that are signing up for these studies have already exhausted many other avenues, leaving us people who have a very short time to live, and a lesser chance for the combo to work.. (so when it does, it's amazing, hence the results being increadible).

2. That we struggle to get people to sign up.

As the results are more known, and specialists could recommend THIS experimental therapy we will fill studies much easier.

Now..

As a stock. (In my time), I have owned vla for probably 2 years, and it has been primed for a takeover since then. Via medical journals and ratings agencies, but still we are here..

the hardest thing about owning this stock is to consider selling it, and the what if, its almost a given that soon someone with deep pockets will licence cavatac, or take over vla. When is the problem.

Then the fear is if time is taken and a BETTER 'cure' is found, cavatac may be worthless..